IT1170838B - Soluzioni concentrate stabili di cisplatina utili come composizioni farmaceutiche e relativo procedimento di produzione - Google Patents

Soluzioni concentrate stabili di cisplatina utili come composizioni farmaceutiche e relativo procedimento di produzione

Info

Publication number
IT1170838B
IT1170838B IT48090/81A IT4809081A IT1170838B IT 1170838 B IT1170838 B IT 1170838B IT 48090/81 A IT48090/81 A IT 48090/81A IT 4809081 A IT4809081 A IT 4809081A IT 1170838 B IT1170838 B IT 1170838B
Authority
IT
Italy
Prior art keywords
cisplatin
useful
pharmaceutical compositions
production process
concentrated solutions
Prior art date
Application number
IT48090/81A
Other languages
English (en)
Italian (it)
Other versions
IT8148090A0 (it
Inventor
Murray A Kaplan
Alphonse P Granatek
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of IT8148090A0 publication Critical patent/IT8148090A0/it
Application granted granted Critical
Publication of IT1170838B publication Critical patent/IT1170838B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IT48090/81A 1980-03-31 1981-03-24 Soluzioni concentrate stabili di cisplatina utili come composizioni farmaceutiche e relativo procedimento di produzione IT1170838B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13537380A 1980-03-31 1980-03-31

Publications (2)

Publication Number Publication Date
IT8148090A0 IT8148090A0 (it) 1981-03-24
IT1170838B true IT1170838B (it) 1987-06-03

Family

ID=22467813

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48090/81A IT1170838B (it) 1980-03-31 1981-03-24 Soluzioni concentrate stabili di cisplatina utili come composizioni farmaceutiche e relativo procedimento di produzione

Country Status (30)

Country Link
JP (1) JPS56152415A (sv)
KR (1) KR860000841B1 (sv)
AR (1) AR225500A1 (sv)
AT (1) AT370996B (sv)
AU (1) AU541056B2 (sv)
BE (1) BE888209A (sv)
CA (1) CA1162479A (sv)
CH (1) CH647481A5 (sv)
CS (1) CS246051B2 (sv)
DD (1) DD157762A5 (sv)
DE (1) DE3112272A1 (sv)
DK (1) DK158564C (sv)
ES (1) ES500869A0 (sv)
FI (1) FI70670C (sv)
FR (1) FR2480605A1 (sv)
GB (1) GB2074028B (sv)
GR (1) GR72769B (sv)
HU (1) HU183379B (sv)
IE (1) IE51070B1 (sv)
IL (1) IL62517A (sv)
IT (1) IT1170838B (sv)
LU (1) LU83270A1 (sv)
NL (1) NL8101531A (sv)
NO (1) NO156675C (sv)
NZ (1) NZ196519A (sv)
PH (1) PH17152A (sv)
PT (1) PT72774B (sv)
SE (1) SE455045B (sv)
SU (1) SU1056893A3 (sv)
ZA (1) ZA812084B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
FI895340A0 (fi) * 1988-11-14 1989-11-09 Bristol Myers Squibb Co Hypertonisk cisplatin-loesning.
DE69725747T2 (de) * 1996-08-23 2004-07-29 Sequus Pharmaceuticals, Inc., Menlo Park Liposome enthaltend cisplatin
AUPQ641100A0 (en) 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
JP4445304B2 (ja) 2004-03-26 2010-04-07 オンキヨー株式会社 スイッチングアンプ
US8852566B2 (en) * 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
KR20200136997A (ko) 2018-03-29 2020-12-08 프로젝트 파마슈틱스 게엠베하 액체 약학적 제형

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method
SE445172B (sv) * 1978-05-30 1986-06-09 Bristol Myers Co Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform

Also Published As

Publication number Publication date
GB2074028A (en) 1981-10-28
BE888209A (fr) 1981-09-30
FR2480605B1 (sv) 1984-05-11
DE3112272C2 (sv) 1990-09-27
AR225500A1 (es) 1982-03-31
DK144281A (da) 1981-10-01
DD157762A5 (de) 1982-12-08
JPS6360008B2 (sv) 1988-11-22
DK158564C (da) 1990-11-05
IE51070B1 (en) 1986-09-17
NZ196519A (en) 1983-06-17
IE810715L (en) 1981-09-30
IL62517A (en) 1984-01-31
SU1056893A3 (ru) 1983-11-23
CA1162479A (en) 1984-02-21
DK158564B (da) 1990-06-11
ES8206545A1 (es) 1982-08-16
IL62517A0 (en) 1981-05-20
AU6816681A (en) 1981-10-08
AT370996B (de) 1983-05-25
CH647481A5 (fr) 1985-01-31
HU183379B (en) 1984-04-28
PT72774B (en) 1982-11-16
DE3112272A1 (de) 1982-04-29
PT72774A (en) 1981-04-01
GB2074028B (en) 1983-09-21
SE455045B (sv) 1988-06-20
ZA812084B (en) 1982-04-28
NO156675C (no) 1987-11-04
JPS56152415A (en) 1981-11-26
FI810934L (fi) 1981-10-01
KR830004849A (ko) 1983-07-20
FR2480605A1 (fr) 1981-10-23
PH17152A (en) 1984-06-13
ATA150481A (de) 1982-10-15
IT8148090A0 (it) 1981-03-24
FI70670C (fi) 1986-10-06
CS246051B2 (en) 1986-10-16
FI70670B (fi) 1986-06-26
NL8101531A (nl) 1981-10-16
AU541056B2 (en) 1984-12-13
LU83270A1 (fr) 1981-10-29
KR860000841B1 (ko) 1986-07-09
NO156675B (no) 1987-07-27
GR72769B (sv) 1983-12-02
SE8101990L (sv) 1981-11-13
ES500869A0 (es) 1982-08-16
NO811081L (no) 1981-10-01

Similar Documents

Publication Publication Date Title
IT1116493B (it) Procedimento per la produzione di interferon e composizioni che lo contengono
IT1115800B (it) Derivati dell'imidazolo relativo procedimento di produzione e composizioni farmaceutiche che li contengono come ingrediente attivo
IT1120977B (it) Derivati di acidi fenossialchilcar bossilici particolarmente utili come medicamenti
FR2358418A1 (fr) Nouveaux polygalactosidosaccharoses sulfates utiles notamment comme inhibiteurs du complement
IT1074295B (it) Procedimento per la preparazione di derivati dell acido fusidico particolarmente utili come batteri cidi
IT8267668A0 (it) Derivati dell ammidinopiperidina particolarmente utili come medicamenti e procedimento per la loro produzione
IT1170838B (it) Soluzioni concentrate stabili di cisplatina utili come composizioni farmaceutiche e relativo procedimento di produzione
IT7949927A0 (it) Imidazochinossaline e loro sali,loro procedimento di produzione,loro impiego come medicamenti e composizioni farmaceutiche che le contengono
IT8322648A0 (it) Derivati dell'acido 4-fenil4-osso-buten 2-oico, loro procedimento di preparazione e loro applicazione come prodotti medicinali.
IT8167382A0 (it) Procedimento di preparazione di colorante giallo diretto 11 sottoforma di soluzioni concentrate stabili soluzioni ottenute e loro applicazioni
IT1174760B (it) Derivati di acido 4-idrossi 3-chinolin carbossilico sostituiti in 2,loro preparazione,loro applicazione come medicamenti,composizioni che li contengono ed imtermedi ottenuti
IT1141998B (it) Derivati pirazolopiridinici utili come cardiotonici e loro preparazione
IT1161974B (it) Derivti dell acido cis.i 2 epossipropilfosfonico loro procedimento di preparazione e composizioni farmaceutiche che li contengono
ATE24716T1 (de) Lenkotrien-antagonisten.
IT1228934B (it) Derivati dell'acido 7-ossabiciclo (2.2.1.) eptan idrossammico utili come inibitori duplici
FR2426683A1 (fr) Nouvelles 1,2,4-triazolidin-3-ones ou -thiones et leurs methodes de preparation
IT8224755A0 (it) Nuovi derivati di acidi fenilacetici, loro preparazione e composizioni che li contengono.
IT8167391A0 (it) Derivati di amminoacidi particolarmente utili come medicamenti e procedimento per la loro preparazione
IT1092701B (it) Etere cis-e trans-3,3,5-trimetilcicloesiletilic o e loro miscugli come profumi,composizioni di profumi che li contengono e processo di produzione migliorato dell'etere trans-3,3,5-trimetil-cicloesil-etilico
IT8221373A0 (it) Derivati di acido aril- ed eteroarilmercapto-alcanico utili come additivi antiseborroici per cosmetici.
IT1164677B (it) Derivati di 1,3 benzodiossina procedimento per la loro produzione e composizioni farmaceutiche che li contengono come incredienti attivi
IT7826520A0 (it) Derivati dell'acido citrico utili come ammorbidenti.
IT1157231B (it) Derivati monosostituiti dell'acido 4-fenil 4-osso buten-2-cico, utili come medicamenti, e le composizioni che li contengono
DE3466530D1 (de) 2,2-diethoxypropionic acid derivatives
IT8224576A0 (it) Derivati di acidi aminopiridincarbossilici,loro metodi di sintesi e composizioni farmaceutiche che licontengono